Bader Alajlan, M.b.b.s
Chronic disease →Telehealth platform
Independent
Session types
Video & Phone
Languages
English
Are you Bader Alajlan, M.b.b.s?
Claim your profile to verify your insurance, update your bio, add your booking link, and get a Verified badge that builds patient trust. Free tier goes live instantly — no card required.
Claim your profileLooking for a patient? Here's what to know
This profile shows public registry data — name, specialty, and licensed states are confirmed via the federal NPI database. Insurance accepted, current bio, and booking links haven't been confirmed by Bader yet. To verify if they take your insurance or are accepting new patients, contact their practice directly.
About
Dr. Bader Alajlan is an M.B.B.S.-trained physician specializing in chronic disease management with a focus on optimizing long-term health outcomes for patients with complex, ongoing medical conditions. He provides comprehensive telehealth consultations for chronic disease assessment, medication management, and disease progression monitoring. Dr. Alajlan is licensed to practice in Colorado and brings clinical expertise in managing multiple chronic conditions through evidence-based treatment protocols.
Services offered
Dr. Alajlan provides telehealth consultations for patients managing chronic diseases including diabetes, hypertension, heart disease, and respiratory conditions such as COPD and asthma. He specializes in medication optimization, disease monitoring, and developing personalized treatment plans designed to reduce complications and improve quality of life. During typical telehealth visits, Dr. Alajlan reviews medical history, assesses current symptoms, interprets laboratory results, adjusts medications as needed, and provides patient education on lifestyle modifications and disease self-management. He works with patients seeking ongoing care coordination, second opinions on chronic condition management, and support in controlling multiple concurrent health conditions to achieve better long-term outcomes.